We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

99 hedge funds and large institutions have $614M invested in Editas Medicine in 2017 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 32 increasing their positions, 17 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 15

88% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 17

61% more capital invested

Capital invested by funds: $381M → $614M (+$233M)

18% more funds holding

Funds holding: 84 → 99 (+15)

3.54% more ownership

Funds ownership: 64.09% → 67.63% (+3.5%)

31% less call options, than puts

Call options by funds: $5.38M | Put options by funds: $7.75M

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

Holders
99
Holders Change
+15
Holders Change %
+17.86%
% of All Funds
2.46%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
35
Increased
32
Reduced
17
Closed
15
Calls
$5.38M
Puts
$7.75M
Net Calls
-$2.37M
Net Calls Change
-$2.61M

Top Buyers

1
Capital World Investors
Capital World Investors
California
+$30.6M
2
BlackRock
BlackRock
New York
+$23.2M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$12.8M
4
Millennium Management
Millennium Management
New York
+$11.5M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$8.35M

Top Sellers

1
EC
EcoR1 Capital
California
-$10.2M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$4.76M
3
FCMI
Foresite Capital Management III
California
-$4.46M
4
FP
Flagship Pioneering
Massachusetts
-$1.64M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$1.54M
Name Holding Trade Value Shares
Change 		Change in
Stake
Zurich Cantonal Bank
76
Zurich Cantonal Bank
Switzerland
$38K – – –
Barclays
77
Barclays
United Kingdom
$37K -$10.1K -487 -23%
Deutsche Bank
78
Deutsche Bank
Germany
$36K -$59.9K -2,890 -64%
AG
79
Advisor Group
Arizona
$36K +$33.2K +1,600 New
EDRH
80
Edmond de Rothschild Holding
Switzerland
$33K +$31.1K +1,500 New
LTFS
81
Ladenburg Thalmann Financial Services
Florida
$24K -$6.84K -330 -23%
Canada Life
82
Canada Life
Manitoba, Canada
$18K – – –
RAM
83
Riggs Asset Management
Pennsylvania
$16K +$14.5K +700 New
TIM
84
Tortoise Investment Management
New York
$15K – – –
Bank of Montreal
85
Bank of Montreal
Ontario, Canada
$13K – – –
MFW
86
Mosaic Family Wealth
Missouri
$12K – – –
AIP
87
Ameritas Investment Partners
Nebraska
$12K +$10.9K +525 New
BNP Paribas Financial Markets
88
BNP Paribas Financial Markets
France
$9.84K -$4K -193 -30%
IA
89
IFP Advisors
Florida
$9K +$8K +386 New
CFD
90
Creative Financial Designs
Indiana
$7K +$6.22K +300 New
TCM
91
Tradewinds Capital Management
Washington
$6K – – –
JP Morgan Chase
92
JP Morgan Chase
New York
$6K +$5.18K +250 New
Citigroup
93
Citigroup
New York
$4K -$190K -9,192 -98%
MAM
94
Meeder Asset Management
Ohio
$4K -$5.62K -271 -59%
CHP
95
Cable Hill Partners
Oregon
$4K – – –
SPIA
96
Steward Partners Investment Advisory
New York
$4K – – –
Creative Planning
97
Creative Planning
Kansas
$2K -$69.2K -3,339 -97%
GAM
98
Gemmer Asset Management
California
$2K +$1.97K +95 New
CCM
99
Cribstone Capital Management
Maine
$2K +$2.18K +105 New
EC
100
EcoR1 Capital
California
– -$10.2M -626,762 Closed
1 2 3
4
5

EDIT Hedge Fund Activity: Q1 2017 in Review

99 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q1 2017, worth a combined $614M — up 61% from $381M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new EDIT positions and 15 closed out — a net gain of 20 holders — while 32 added to existing stakes and 17 trimmed.

The largest buyer was Capital World Investors, adding an estimated $30.6M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $10.2M sold.

  • 99 institutional investors held Editas Medicine (EDIT) as of Q1 2017, up from 84 in Q4 2016.
  • Funds reported $614M of Editas Medicine stock for Q1 2017, up 61% quarter-over-quarter.
  • 35 funds opened new Editas Medicine positions in Q1 2017 and 15 closed out, a net change of +20 holders.
  • The largest Editas Medicine buyer in Q1 2017 was Capital World Investors, an estimated $30.6M added.
  • The largest Editas Medicine seller in Q1 2017 was EcoR1 Capital, an estimated $10.2M sold.

Based on aggregated 13F filings for Q1 2017.